Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance

BACKGROUND: Osteosarcoma is the most common bone malignancy in children and adolescents, and 20%–30% of the patients suffer from poor prognosis because of individual chemoresistance. The Hippo/yes-associated protein (YAP) signaling pathway has been shown to play a role in tumor chemoresistance, but...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Chin J Cancer
Main Authors: Wang, Dong-Yu, Wu, Ya-Nan, Huang, Jun-Qi, Wang, Wei, Xu, Meng, Jia, Jin-Peng, Han, Gang, Mao, Bei-Bei, Bi, Wen-Zhi
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4875723/
https://ncbi.nlm.nih.gov/pubmed/27206784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40880-016-0109-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados